X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-28 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $3.03 | -912,000 | 4,937,007 | -16% | -$2,766,039 | |||||
2024-08-27 | NVTS | Kinzer Daniel M. | COO, CTO | S - Sale | $3.10 | -150,000 | 4,388,353 | -3% | -$465,045 | ||||||
2024-08-15 | NVTS | Moxam David | Dir | S - Sale | $3.13 | -33,000 | 867,848 | -4% | -$103,260 | ||||||
| M | 2024-06-06 | NVTS | Saluja Dipender | Dir | S - Sale | $4.50 | -261,179 | 9,260,230 | -3% | -$1,175,584 | |||||
2024-03-14 | NVTS | Singh Ranbir | EVP, GeneSic Business, 10% | S - Sale | $4.80 | -10,925 | 24,912,518 | 0% | -$52,451 | ||||||
2024-03-14 | NVTS | Kinzer Daniel M. | COO, CTO | S - Sale | $4.80 | -24,073 | 4,538,353 | -1% | -$115,574 | ||||||
2024-03-14 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $4.80 | -38,431 | 5,849,007 | -1% | -$184,507 | ||||||
2023-12-15 | NVTS | Shelton Ron | SVP, CFO, Treasurer | S - Sale | $8.11 | -10,000 | 306,668 | -3% | -$81,101 | ||||||
| M | 2023-12-12 | NVTS | Saluja Dipender | Dir | S - Sale | $7.88 | -174,119 | 9,489,949 | -2% | -$1,372,027 | |||||
2023-12-07 | NVTS | Shelton Ron | SVP, CFO, Treasurer | S - Sale | $7.54 | -30,000 | 316,668 | -9% | -$226,059 | ||||||
2023-11-14 | NVTS | Hendrix Richard J | Dir | S - Sale | $6.29 | -49,150 | 3,362,028 | -1% | -$309,217 | ||||||
2023-11-14 | NVTS | Wunderlich Gary Kent Jr | Dir | S - Sale | $6.29 | -49,150 | 3,393,745 | -1% | -$309,217 | ||||||
| M | 2023-11-02 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $5.97 | -33,332 | 5,784,003 | -1% | -$199,145 | |||||
| M | 2023-10-05 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $6.39 | -33,332 | 5,817,335 | -1% | -$213,116 | |||||
| M | 2023-09-05 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $8.61 | -33,532 | 3,856,123 | -1% | -$288,714 | |||||
2023-09-01 | NVTS | Hendrix Richard J | Dir | S - Sale | $8.85 | -20,000 | 4,885,956 | 0% | -$177,014 | ||||||
| M | 2023-08-28 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $8.28 | -912,000 | 3,889,655 | -19% | -$7,549,137 | |||||
| M | 2023-08-28 | NVTS | Kinzer Daniel M. | COO, CTO | S - Sale | $8.28 | -174,532 | 4,498,315 | -4% | -$1,444,699 | |||||
| M | 2023-08-23 | NVTS | Shelton Ron | SVP, CFO, Treasurer | S - Sale | $8.41 | -73,639 | 346,668 | -18% | -$619,004 | |||||
| M | 2023-08-24 | NVTS | Wunderlich Gary Kent Jr | Dir | S - Sale | $8.42 | -49,935 | 4,880,947 | -1% | -$420,458 | |||||
2023-08-17 | NVTS | Shelton Ron | SVP, CFO, Treasurer | S - Sale | $7.81 | -34,245 | 420,307 | -8% | -$267,453 | ||||||
| M | 2023-08-02 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $9.98 | -41,024 | 5,151,655 | -1% | -$409,559 | |||||
| M | 2023-07-05 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $10.42 | -56,408 | 5,192,679 | -1% | -$587,579 | |||||
| M | 2023-06-14 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $9.90 | -41,040 | 5,249,087 | -1% | -$406,490 | |||||
2023-03-17 | NVTS | Singh Ranbir | EVP, GeneSic Business, 10% | S - Sale | $6.55 | -1,556 | 24,885,913 | 0% | -$10,192 | ||||||
2023-03-14 | NVTS | Singh Ranbir | EVP, GeneSic Business, 10% | S - Sale | $6.46 | -18,645,603 | 24,883,161 | -43% | -$120,450,595 | ||||||
2023-03-15 | NVTS | Sheridan Eugene | Pres, CEO | S - Sale | $6.30 | -38,521 | 5,290,127 | -1% | -$242,682 | ||||||
2023-03-15 | NVTS | Shelton Ron | SVP, CFO, Treasurer | S - Sale | $6.30 | -3,313 | 379,552 | -1% | -$20,872 | ||||||
2023-03-15 | NVTS | Kinzer Daniel M. | COO, CTO | S - Sale | $6.30 | -8,990 | 4,669,847 | 0% | -$56,637 | ||||||
2023-02-27 | NVTS | Moxam David | Dir | S - Sale | $6.17 | -81,566 | 854,367 | -9% | -$503,262 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |